ELIAN'S BIOMEDICAL SOLUTIONS LTD

Executive Summary

ELIAN'S BIOMEDICAL SOLUTIONS LTD is currently dormant with no trading activity and negative net assets, indicating financial distress. The company faces liquidity challenges and has eroded equity, requiring strategic capital injection and operational reassessment to restore financial health. Immediate focus on liability management and business revival is essential to improve its outlook.

ELIAN'S BIOMEDICAL SOLUTIONS LTD - Analysis Report

Company Number: 13053862

Analysis Date: 2025-07-29 17:29 UTC

Financial Health Assessment: ELIAN'S BIOMEDICAL SOLUTIONS LTD

---

1. Financial Health Score: Grade D

Explanation:
The company currently shows signs of financial dormancy and distress. It has consistently reported net liabilities with negative net assets from 2022 onwards, indicating an unhealthy financial state. While it is active, the absence of trading activity combined with persistent liabilities and negative equity suggests the company is in a fragile condition financially. This warrants a D grade—indicating poor financial health and the need for strategic intervention to restore vitality.

---

2. Key Vital Signs

Metric	Latest Value (31/03/2024)	Interpretation
Trading Activity	Dormant (no turnover)	No trading or revenue generation during the year; company is inactive operationally.
Net Assets (Equity)	-£1,479	Negative net assets indicate liabilities exceed assets; a symptom of financial distress.
Current Liabilities	£1,479	Company owes £1,479 due within one year; payable obligations exist despite no trading.
Net Current Assets (Working Capital)	-£1,479	Negative working capital means current liabilities outstrip current assets; poor liquidity sign.
Share Capital	£11	Minimal paid-up share capital; little equity cushion to absorb losses or risks.
Historical Asset Position	Fixed assets £0 (last year)	The company has no tangible assets to leverage or sell for cash.
Employee Count	1	Single director/employee, reflecting a micro-level operation.

---

3. Diagnosis

Symptoms Analysis:

• The company has transitioned from a small operational entity with positive net assets in 2020-21 (~£5,100 equity) to a dormant state with ongoing net liabilities from 2022 onwards.
• No turnover or trading activity has been recorded for multiple years, consistent with its Dormant account category. This suggests the business is not currently generating income or cash flow, which is akin to a patient not eating or metabolizing nutrients—cash inflow is zero.
• Persistent current liabilities without corresponding current assets imply obligations the company cannot cover with short-term resources, a liquidity problem akin to a patient with insufficient blood flow to vital organs.
• Negative net assets (shareholders' funds) indicate accumulated losses or write-downs that have eroded equity, reflecting a weakened financial immune system.
• The minimal share capital (£11) means there is limited buffer against financial shocks or operating losses.

Overall Diagnosis:
ELIAN'S BIOMEDICAL SOLUTIONS LTD is financially dormant and distressed. It is not generating revenue, has liabilities exceeding assets, and faces liquidity constraints. The company is essentially in a state of financial hibernation with symptoms of underlying structural inactivity and capital erosion.

---

4. Recommendations

To improve financial wellness and restore operational vitality, the company should consider the following actions:

1. Reassess Business Strategy:

   • Evaluate reasons behind dormancy. Is the company intentionally on hold (e.g., awaiting investment, market conditions) or inactive due to operational failure?
   • Revive trading activities or pivot business model based on market opportunities in biomedical solutions.

2. Address Liabilities:

   • Negotiate payment terms or settle outstanding current liabilities to reduce immediate financial pressure.
   • If liabilities are related to one-off or historic costs, consider restructuring.

3. Capital Injection:

   • Increase share capital or seek equity investment to restore positive net assets and improve balance sheet strength.
   • This acts like providing a blood transfusion to revive financial health.

4. Cost Management:

   • Minimize ongoing expenses during dormancy to conserve cash and avoid increasing liabilities.
   • Consider formal closure or dormancy filings if business resumption is not imminent.

5. Compliance & Reporting:

   • Maintain timely filing of accounts and confirmation statements to avoid penalties and maintain good standing.

6. Professional Advice:

   • Engage financial advisors to explore restructuring options or potential sale/acquisition opportunities.

---